查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298512

心室輔助設備市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

全球心室輔助設備市場規模在2022年達到17億美元。展望未來，IMARC Group預計到2028年市場規模將達到31億美元，在2023-2028年期間表現出9.7%的成長率（CAGR）。

心室輔助設備（VAD），也被稱為機械循環支持設備，是一種機械泵，將血液從心臟下腔輸送到身體的其他部位。它通常由三個部分組成，包括管道、電子控制器和電源。管子將血液輸送到泵中，並將其輸送到血管中，而電源則與控制單元相連，用於監測VAD的功能。該設備被植入患者體內，作為術後或等待心臟移植時支持心臟功能的短期治療。它被應用於移植橋（BTT）、恢復橋（BTR）、候選橋（BTC）和目的地療法。

高血壓、室間隔缺損、心力衰竭和中風等心血管疾病病例的增加，是推動全球VAD市場成長的重要因素之一。此外，心臟捐贈者的數量有限，使全球各地對VAD的需求不斷增加。為了克服這種短缺，醫療機構正專注於利用VADs來保持血液循環，直到新的心臟被植入。這有助於降低醫院的死亡率、住院時間和總體醫院成本。此外，該行業的領先製造商正在涵蓋技術進步，如帶有感染控制技術的微型設備，以解決感染、血栓形成和血液創傷的高風險等併發症。除此之外，還在進行一些臨床試驗，通過提高設備的耐用性、功能和效率來提高存活率。

本報告中回答的關鍵問題：

  • 迄今為止，全球心室輔助設備市場的表現如何，在未來幾年將如何表現？
  • 主要的區域市場是什麼？
  • COVID-19對全球心室輔助設備市場的影響是什麼？
  • 基於產品的市場細分是什麼？
  • 基於流量類型的市場細分是什麼？
  • 基於產品類型的市場詳細情形是怎樣的？
  • 基於應用的市場細分是什麼？
  • 基於終端用戶的市場細分是什麼？
  • 該行業價值鏈的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球心室輔助設備市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球心室輔助設備市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按產品分類的市場

  • 左心室輔助設備(LVAD)
    • 市場趨勢
    • 市場預測
  • 右心室輔助設備(RVAD)
    • 市場趨勢
    • 市場預測
  • 雙心室輔助設備(BiVAD)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：按流量類型分類的市場

  • 脈動流
    • 市場趨勢
    • 市場預測
  • 非脈動或連續流
    • 市場趨勢
    • 市場預測

第八章：按產品類型分類的市場

  • 植入式心室輔助設備
    • 市場趨勢
    • 市場預測
  • 非植入式心室輔助設備
    • 市場趨勢
    • 市場預測

第九章：按應用分類的市場

  • 橋接移植（BTT）療法
    • 市場趨勢
    • 市場預測
  • 目的地療法
    • 市場趨勢
    • 市場預測
  • 恢復之橋和候選之橋
    • 市場趨勢
    • 市場預測

第十章：按終端用戶分類的市場

  • 非住院手術中心
    • 市場趨勢
    • 市場預測
  • 醫院
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十一章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十二章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十三章：價值鏈分析

第十四章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第15章：價格指標

第16章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH (Syscore GmbH)
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc. (LivaNova PLC)
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH (Getinge)
    • Medtronic Inc.
    • Syncardia Systems LLC (Versa Capital Management LLC)
    • TandemLife (LivaNova Plc)
    • Terumo Corporation
Product Code: SR112023A2276

The global ventricular assist devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.7% during 2023-2028.

A ventricular assist device (VAD), also known as a mechanical circulatory support device, is a mechanical pump that transports blood from the lower chambers of the heart to the rest of the body. It generally comprises three components, which include tubes, an electronic controller and a power source. The tubes carry blood into the pump and transfer it into blood vessels, while the power source is connected to a control unit for monitoring the functions of the VAD. The device is implanted in patients as a short-term treatment for supporting heart functions after surgery or while they are waiting for a heart transplant. It finds application in the bridge-to-transplant (BTT), bridge-to-recovery (BTR), bridge-to-candidacy (BTC) and destination therapies.

The increasing cases of cardiovascular diseases, such as hypertension, ventricular septal defect, heart failure and stroke, represents one of the significant factors propelling the global VAD market growth. Moreover, the limited number of heart donors is escalating the demand for VADs across the globe. In order to overcome this shortage, healthcare providers are focusing on the utilization of VADs to keep the blood pumping until a new heart is implanted. This helps in reducing the hospital mortality rate, length of stay and overall hospital costs. Furthermore, the leading manufacturers in the industry are incorporating technological advancements, such as miniature devices with infection control technology, to address complications, such as the high risk of infection, thrombus formation and blood trauma. Apart from this, several clinical trials are being undertaken to improve the survival rate by enhancing the durability, functionality and efficiency of the devices.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, flow type, product type, application and end-user.

Breakup by Product:

Left Ventricular Assist Device (LVAD)

Right Ventricular Assist Device (RVAD)

Biventricular Assist Device (BiVAD)

Others

Breakup by Flow Type:

Pulsatile Flow

Non-Pulsatile or Continuous Flow

Breakup by Product Type:

Implantable Ventricular Assist Devices

Non-implantable Ventricular Assist Devices

Breakup by Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge to Recovery and Bridge to Candidacy

Breakup by End-User:

Ambulatory Surgery Centers

Hospital

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH (Syscore GmbH), Bivacor Inc., Calon Cardio, Cardiacassist Inc. (LivaNova PLC), CHF Solutions Inc., Jarvik Heart Inc., MAQUET GmbH (Getinge), Medtronic Inc., Syncardia Systems LLC (Versa Capital Management LLC), TandemLife (LivaNova PLC), Terumo Corporation, etc.

Key Questions Answered in This Report:

  • How has the global ventricular assist devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global ventricular assist devices market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the flow type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ventricular assist devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2022
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2022
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2022
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2023-2028
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players